NDLI: The Novel PKCθ from Benchtop to Clinic

Content Provider	PubMed Central
Author	Rouba, Hage-sleiman Hamze, Asmaa B. Lina, Reslan Kobeissy, Hadile Ghassan, Dbaibo
Copyright Year	2015
Abstract	The protein kinases C (PKCs) are a family of serine/threonine kinases involved in regulating multiple essential cellular processes such as survival, proliferation, and differentiation. Of particular interest is the novel, calcium-independent PKCθ which plays a central role in immune responses. PKCθ shares structural similarities with other PKC family members, mainly consisting of an N-terminal regulatory domain and a C-terminal catalytic domain tethered by a hinge region. This isozyme, however, is unique in that it translocates to the immunological synapse between a T cell and an antigen-presenting cell (APC) upon T cell receptor-peptide MHC recognition. Thereafter, PKCθ interacts physically and functionally with downstream effectors to mediate T cell activation and differentiation, subsequently leading to inflammation. PKCθ-specific perturbations have been identified in several diseases, most notably autoimmune disorders, and hence the modulation of its activity presents an attractive therapeutic intervention. To that end, many inhibitors of PKCs and PKCθ have been developed and tested in preclinical and clinical studies. And although selectivity remains a challenge, results are promising for the future development of effective PKCθ inhibitors that would greatly advance the treatment of several T-cell mediated diseases.
Related Links	http://dx.doi.org/10.1155/2015/348798
Starting Page	348798
File Format	PDF
ISSN	23147156
e-ISSN	23147156
Journal	Journal of Immunology Research
Volume Number	2015
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2015-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The Novel PKCθ from Benchtop to Clinic

The new ParaDIgm: IgM from bench to clinic

PKCθ Signals Activation versus Tolerance In Vivo

Transplantation tolerance: from theory to clinic

Human asthma phenotypes: from the clinic, to cytokines, and back again

Translating Costimulation Blockade to the Clinic: Lessons Learned from Three Pathways

CTLA-4: From conflict to clinic

PI3K – From the Bench to the Clinic and Back

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

The Novel PKCθ from Benchtop to Clinic

Similar Documents

The Novel PKCθ from Benchtop to Clinic

The new ParaDIgm: IgM from bench to clinic

PKCθ Signals Activation versus Tolerance In Vivo

Transplantation tolerance: from theory to clinic

Human asthma phenotypes: from the clinic, to cytokines, and back again

Translating Costimulation Blockade to the Clinic: Lessons Learned from Three Pathways

CTLA-4: From conflict to clinic

PI3K – From the Bench to the Clinic and Back

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

The Novel PKCθ from Benchtop to Clinic